Patents by Inventor Nobuhiko DOJUN

Nobuhiko DOJUN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20260248139
    Abstract: A novel bacteriophage having bacteriolytic activity against bacteria of the genus Salmonella, such as S. Enteritidis, and a bacteriolytic agent consisting of the same are provided. The bacteriophage and the bacteriolytic agent including the bacteriophage have a wide host range for bacteria of the genus Salmonella. A host-specific bacteriophage and an effective Salmonella bacteriolytic agent consisting of the same are provided. A bacteriophage capable of effectively controlling S. Typhimurium, and in particular, multidrug-resistant S. Typhimurium, and a bacteriolytic agent consisting of the same are also provided. A bacteriophage having a specific genomic DNA sequence; a Salmonella bacteriolytic agent consisting of the bacteriophage; and a composition comprising the same are provided.
    Type: Application
    Filed: September 30, 2025
    Publication date: August 27, 2026
    Applicants: KANEKA CORPORATION, RAKUNO GAKUEN UNIVERSITY, MITSUI & CO., LTD.
    Inventors: Shinichi Yoshida, Nobuhiko Dojun, Hidetomo Iwano, Ryo Murata, Ikuo Uchida, Yoshifumi Hatanaka
  • Publication number: 20260248866
    Abstract: An object of the present disclosure is to provide (i) a novel bacteriophage having lytic activity against a Salmonella species such as S. enteritidis or a lytic agent including the same, (ii) a bacteriophage having a broad host range against Salmonella species or a lytic agent including the same, (iii) a host-specific bacteriophage or an effective lytic agent for a Salmonella species including the same, or (iv) a bacteriophage or a lytic agent including the same, capable of effectively controlling S. typhimurium, particularly S. typhimurium having multidrug resistance. The present disclosure provides bacteriophages having specific genomic DNA sequences, lytic agents for Salmonella species including the same, and compositions including the same.
    Type: Application
    Filed: September 30, 2025
    Publication date: August 27, 2026
    Applicants: KANEKA CORPORATION, RAKUNO GAKUEN UNIVERSITY, MITSUI & CO., LTD.
    Inventors: Shinichi Yoshida, Nobuhiko Dojun, Hidetomo Iwano, Ryo Murata, Ikuo Uchida, Yoshifumi Hatanaka
  • Publication number: 20260248865
    Abstract: A bacteriophage having a wide host range for bacteria of the genus Salmonella is provided. The bacteriophage has bacteriolytic activity against bacteria of the genus Salmonella. The bacteriophage has a genomic DNA sequence comprising a gene encoding a tail tip protein consisting of a specific amino acid sequence. Methods of using the bacteriophage are also provided.
    Type: Application
    Filed: September 30, 2025
    Publication date: August 27, 2026
    Applicants: KANEKA CORPORATION, RAKUNO GAKUEN UNIVERSITY, MITSUI & CO., LTD.
    Inventors: Shinichi Yoshida, Nobuhiko Dojun, Hidetomo Iwano, Ryo Murata, Ikuo Uchida, Yoshifumi Hatanaka
  • Publication number: 20260096561
    Abstract: Methods are provided for controlling a plant disease caused by a bacterium of genus Xanthomonas, comprising contacting a bacteriophage to a target plant, and for identifying a bacterium of the genus Xanthomonas, involving: culturing a test bacterium isolated from a plant tissue affected by a plant disease to obtain a culture; mixing the culture with a bacteriophage to obtain a mixture; culturing the mixture under a predetermined condition; and determining that the test bacteria are bacteria of the genus Xanthomonas when the test bacteria are lysed after the mixture-culturing step.
    Type: Application
    Filed: November 26, 2025
    Publication date: April 9, 2026
    Applicants: KANEKA CORPORATION, RAKUNO GAKUEN UNIVERSITY, MITSUI & CO., LTD.
    Inventors: Shinichi Yoshida, Nobuhiko Dojun, Hidetomo Iwano, Hitoshi Kudo
  • Publication number: 20260076375
    Abstract: A composition for plant disease control containing a bacteriophage, wherein the composition for plant disease control is inhibited from decreasing in the bacteriolytic activity or maintains the bacteriolytic activity, and has excellent persistence characteristics, is provided. The composition for plant disease control contains a bacteriophage with bacteriolytic activity against bacteria and an organic silicone-based surfactant.
    Type: Application
    Filed: September 29, 2025
    Publication date: March 19, 2026
    Applicants: KANEKA CORPORATION, MITSUI & CO., LTD.
    Inventors: Nobuhiko Dojun, Shinichi Yoshida, Hitoshi Kudo
  • Publication number: 20250129129
    Abstract: To control plant diseases caused by Xanthomonas spp., a novel bacteriophage exhibiting bacteriolysis activity specifically on Xanthomonas spp. was isolated. Thus, developed and provided is a plant disease control composition containing the bacteriophage as an active ingredient. Provided are a bacteriolytic agent containing a bacteriophage that has a novel genomic DNA sequence and exhibits bacteriolysis activity specifically on Xanthomonas spp., and a plant disease control composition containing the same as an active ingredient.
    Type: Application
    Filed: September 30, 2024
    Publication date: April 24, 2025
    Applicants: KANEKA CORPORATION, RAKUNO GAKUEN UNIVERSITY, MITSUI & CO., LTD.
    Inventors: Shinichi Yoshida, Nobuhiko Dojun, Mitsuaki Kitano, Hidetomo Iwano, Hitoshi Kudo
  • Publication number: 20250089724
    Abstract: To control plant diseases caused by Xanthomonas spp., a novel bacteriophage exhibiting bacteriolysis activity specifically on Xanthomonas spp. was isolated. Thus, developed and provided is a plant disease control composition containing the bacteriophage as an active ingredient. Provided are a bacteriolytic agent containing a bacteriophage that has a novel genomic DNA sequence and exhibits bacteriolysis activity specifically on Xanthomonas spp., and a plant disease control composition containing the same as an active ingredient.
    Type: Application
    Filed: September 27, 2024
    Publication date: March 20, 2025
    Applicants: KANEKA CORPORATION, RAKUNO GAKUEN UNIVERSITY, MITSUI & CO., LTD.
    Inventors: Shinichi Yoshida, Nobuhiko Dojun, Mitsuaki Kitano, Hidetomo Iwano, Hitoshi Kudo
  • Publication number: 20250089725
    Abstract: To control plant diseases caused by Xanthomonas spp., a novel bacteriophage exhibiting bacteriolysis activity specifically on Xanthomonas spp. was isolated. Thus, developed and provided is a plant disease control composition containing the bacteriophage as an active ingredient. Provided are a bacteriolytic agent containing a bacteriophage that has a novel genomic DNA sequence and exhibits bacteriolysis activity specifically on Xanthomonas spp., and a plant disease control composition containing the same as an active ingredient.
    Type: Application
    Filed: September 30, 2024
    Publication date: March 20, 2025
    Applicants: KANEKA CORPORATION, RAKUNO GAKUEN UNIVERSITY, MITSUI & CO., LTD.
    Inventors: Shinichi Yoshida, Nobuhiko Dojun, Mitsuaki Kitano, Hidetomo Iwano, Hitoshi Kudo
  • Publication number: 20250090608
    Abstract: To control plant diseases caused by Xanthomonas spp., a novel bacteriophage exhibiting bacteriolysis activity specifically on Xanthomonas spp. was isolated. Thus, developed and provided is a plant disease control composition containing the bacteriophage as an active ingredient. Provided are a bacteriolytic agent containing a bacteriophage that has a novel genomic DNA sequence and exhibits bacteriolysis activity specifically on Xanthomonas spp., and a plant disease control composition containing the same as an active ingredient.
    Type: Application
    Filed: September 27, 2024
    Publication date: March 20, 2025
    Applicants: KANEKA CORPORATION, RAKUNO GAKUEN UNIVERSITY, MITSUI & CO., LTD.
    Inventors: Shinichi Yoshida, Nobuhiko Dojun, Mitsuaki Kitano, Hidetomo Iwano, Hitoshi Kudo
  • Publication number: 20230304061
    Abstract: This invention is intended to improve glutathione productivity by fermentation using microorganisms. This invention relates to a microbial strain capable of overexpression of ?-glutamylcysteine, bis-?-glutamylcystine, ?-glutamylcystine, reduced glutathione, and/or oxidized glutathione in which the expression level of a gene encoding serine-O-acetyltransferase (EC:2.3.1.30) is enhanced and a method involving the use of such microbial strain.
    Type: Application
    Filed: April 23, 2021
    Publication date: September 28, 2023
    Applicant: KANEKA CORPORATION
    Inventors: Shingo KOBAYASHI, Nobuhiko DOJUN, Misato MATSUI, Naoaki TAOKA